Greco Fa
- Reproductive Medicine top 5%
- Oncology top 10%
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 4
- Cancer Diagnosis and Treatment 3
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 5
-
- Neuroendocrine Tumor Research Advances 6
-
- Cancer therapeutics and mechanisms 5
-
- ECG Monitoring and Analysis 2
- Journals
- Seminars in Oncology (1 paper)PubMed (28 papers)
- Partner nations
- United States
In The Last Decade
Greco Fa
29 papers receiving 474 citations
Peers
Comparison fields: 5 of 62
- Reproductive Medicine 116
- Oncology 277
- Neurology 81
- Pulmonary and Respiratory Medicine 150
- Epidemiology 153
Countries citing papers authored by Greco Fa
This map shows the geographic impact of Greco Fa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greco Fa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greco Fa more than expected).
Fields of papers citing papers by Greco Fa
This network shows the impact of papers produced by Greco Fa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greco Fa. The network helps show where Greco Fa may publish in the future.
Co-authorship network
The 24 scholars most cited alongside Greco Fa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer. | 2011 | 9 |
| 2 | Evolving role of irinotecan in small-cell lung cancer. | 2003 | 4 |
| 3 | Phase I. Trial of irinotecan plus carboplatin in two dose schedules. | 2003 | 4 |
| 4 | One-hour paclitaxel plus carboplatin for advanced non-small-cell lung cancer. | 1998 | 7 |
| 5 | Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung. | 1997 | 16 |
| 6 | Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site. | 1993 | 17 |
| 7 | Extragonadal germ cell tumors and unrecognized germ cell tumors. | 1992 | 89 |
| 8 | Managing carcinomas of unknown primary site. | 1988 | 2 |
| 9 | Rationale for chemotherapy for patients with advanced non-small-cell lung cancer. | 1986 | 11 |
| 10 | Resistant gestational choriocarcinoma: successful treatment with vinblastine, bleomycin, and cisplatin (VBP). | 1983 | 8 |
| 11 | Phase II evaluation of spirogermanium in advanced ovarian carcinoma. | 1983 | 5 |
| 12 | Complications of treatment of small cell carcinoma of the lung. | 1983 | 21 |
| 13 | Poorly differentiated neoplasms and tumors of unknown origin: introduction. | 1982 | 9 |
| 14 | Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor. | 1980 | 41 |
| 15 | Phase I evaluation of a weekly schedule of anguidine. Southeastern Cancer Study Group Committee on Gastrointestinal Malignancies. | 1980 | 5 |
| 16 | Subclinical adriamycin cardiotoxicity: detection by timing the arterial sounds. | 1978 | 4 |
| 17 | Tumor products and potential markers in small cell lung cancer. | 1978 | 41 |
| 18 | Small cell lung cancer: progress and perspectives. | 1978 | 81 |
| 19 | Spinal cord compression. | 1977 | 1 |
| 20 | Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval). | 1976 | 6 |
About Greco Fa
Greco Fa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology, Reproductive Medicine and Otorhinolaryngology, having authored 29 papers that have together received 533 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (9 papers), Neuroendocrine Tumor Research Advances (6 papers), Cancer therapeutics and mechanisms (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Diagnosis and Treatment (3 papers), Peptidase Inhibition and Analysis (3 papers) and ECG Monitoring and Analysis (2 papers). The work is most often cited by research in Reproductive Medicine (116 citations), Oncology (277 citations), Neurology (81 citations), Pulmonary and Respiratory Medicine (150 citations) and Epidemiology (153 citations). Greco Fa has collaborated with scholars based in United States. Frequent co-authors include Richardson Rl, Oldham Rk, Leslie Burnett, Lawrence H. Einhorn, Bunn Pa, Eagan Rt, Jones Hw, K. Mattson, PE Postmus and Jean Klášterský. Their work appears in journals such as Seminars in Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.